BLOG

Issue 37 of The Altascientist reveals the advantages of Altasciences’ PCR capabilities, and how to integrate them into your gene therapy studies.

Can the drug development industry change for the better? We dive into the obstacles and inefficiencies of the traditional outsourcing paradigm, and discuss how Altasciences offers an alternative to help sponsors safely accelerate their R&D.

Explore the significance of cytokines and the complement system, and the platforms Altasciences uses for monitoring and mitigating adverse effects.

Issue 35 of The Altascientist covers the benefits of high potency drugs, and the considerations for safe, efficient, and regulatory-compliant manufacturing.

This Q&A with Dr. Norbert Makori and Pierre Jolicoeur reveals insights on preclinical gene therapy studies and capabilities at Altasciences’ site in Seattle

Discover the inspiring journey of Altasciences’ Marta Rodriguez, Director of Clinical and Study Operations, who decided to pursue science after her parents fell ill.